|
NGDN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.638400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.300390E-02 |
| Normal-vs-Stage2 |
1.600370E-01 |
| Normal-vs-Stage3 |
2.437700E-02 |
| Normal-vs-Stage4 |
2.421600E-02 |
| Stage1-vs-Stage2 |
2.299400E-03 |
| Stage1-vs-Stage3 |
4.31690000002316E-06 |
| Stage1-vs-Stage4 |
2.42959999999792E-05 |
| Stage2-vs-Stage3 |
8.249600E-01 |
| Stage2-vs-Stage4 |
6.412000E-01 |
| Stage3-vs-Stage4 |
7.354200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.800400E-01 |
| Normal-vs-AfricanAmerican |
1.396360E-02 |
| Normal-vs-Asian |
4.674000E-01 |
| Caucasian-vs-AfricanAmerican |
3.138700E-03 |
| Caucasian-vs-Asian |
4.931800E-01 |
| AfricanAmerican-vs-Asian |
5.347800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.366800E-01 |
| Normal-vs-Female |
1.269020E-01 |
| Male-vs-Female |
5.078700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.936600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.865200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.665800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.267200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.475800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.922000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.917400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.558800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.927800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.551800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.42969999955756E-07 |
| Normal-vs-Grade 2 |
8.038600E-03 |
| Normal-vs-Grade 3 |
2.546200E-02 |
| Normal-vs-Grade 4 |
1.320840E-03 |
| Grade 1-vs-Grade 2 |
8.481200E-03 |
| Grade 1-vs-Grade 3 |
1.52668999999772E-05 |
| Grade 1-vs-Grade 4 |
1.38230000001904E-06 |
| Grade 2-vs-Grade 3 |
3.08039999952214E-07 |
| Grade 2-vs-Grade 4 |
9.786400001488E-08 |
| Grade 3-vs-Grade 4 |
8.804100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.461620E-03 |
| Normal-vs-ccB subtype |
2.959700E-04 |
| ccA subtype-vs-ccB subtype |
4.99489338778858E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.993800E-01 |
| Normal-vs-N1 |
1.89299999997505E-06 |
| N0-vs-N1 |
2.063900E-03 |
|
|
